Associated Papers
Somatic mutations in Middle East and North Africa breast cancer patients: a systematic review.
Abujamous L et al.
The Oncologist, 2025
40665690 (PubMed )
Supplement: oyaf205_supplementary_data.zip › SupplementaryTable3.xlsx › SupplementaryTable3
PIK3CA mutations in breast cancer: A Tunisian series.
Ben Rekaya M et al.
Plos One, 2023
The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China.
Wu H et al.
Cancer Management and Research, 2019
ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
Geißler AL et al.
Oncotarget, 2017
28199979 (PubMed )
Supplement: oncotarget-08-17164-s001.pdf
Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.
Bisht S et al.
Medical Oncology (northwood, London, England), 2014
Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.
Karakas B et al.
Cancer Biology & Therapy, 2013
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.
Barbi S et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2010
Select a paper to view details